P32019 (I5P2_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
January 25, 2012.
Version 112.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Type II inositol-1,4,5-trisphosphate 5-phosphatase EC=3.1.3.36 Alternative name(s): 75 kDa inositol polyphosphate-5-phosphatase Phosphoinositide 5-phosphatase Short name=5PTase | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 993 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Hydrolyzes phosphatidylinositol 4,5-bisphosphate (PtIns(4,5)P2) and the signaling molecule phosphatidylinositol 1,4,5-trisphosphate (PtIns(1,4,5)P3), and thereby modulates cellular signaling events. |
| Catalytic activity | 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + H2O = 1-phosphatidyl-1D-myo-inositol 4-phosphate + phosphate. |
| Subunit structure | |
| Subcellular location | Cytoplasm › cytosol. Membrane; Peripheral membrane protein; Cytoplasmic side. |
| Tissue specificity | Platelets. |
| Post-translational modification | Isoprenylation at Cys-990 may be required for localization at the membrane. |
| Sequence similarities | Belongs to the inositol-1,4,5-trisphosphate 5-phosphatase type II family. Contains 1 Rho-GAP domain. |
| Sequence caution | The sequence AAA79207.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally shortened. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Cytoplasm Membrane |
| Coding sequence diversity | Alternative splicing Polymorphism |
| Molecular function | Hydrolase |
| PTM | Lipoprotein Prenylation |
| Technical term | 3D-structure Complete proteome Direct protein sequencing Reference proteome |
| Gene Ontology (GO) | |
| Biological process | regulation of small GTPase mediated signal transduction Traceable author statement. Source: Reactome small GTPase mediated signal transductionTraceable author statement. Source: Reactome |
| Cellular component | cytosol Traceable author statement. Source: Reactome integral to membraneNon-traceable author statement. Source: UniProtKB microtubule cytoskeletonInferred from direct assay. Source: HPA |
| Molecular function | inositol-polyphosphate 5-phosphatase activity Non-traceable author statement. Source: UniProtKB phosphatidylinositol-4,5-bisphosphate 5-phosphatase activityInferred from electronic annotation. Source: EC protein bindingInferred from physical interaction Ref.7. Source: UniProtKB |
| Complete GO annotation... | |
Alternative products
| This entry describes 4 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: P32019-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Note: No experimental confirmation available. | ||||||
| Isoform 2 (identifier: P32019-2) The sequence of this isoform differs from the canonical sequence as follows: 178-257: Missing. | ||||||
| Isoform 3 (identifier: P32019-3) The sequence of this isoform differs from the canonical sequence as follows: 1-244: Missing. | ||||||
| Isoform 4 (identifier: P32019-4) The sequence of this isoform differs from the canonical sequence as follows: 810-828: TLMPVWTGDDGSQLDSPME → LAYLAAYCFETQLVTKSLI 829-993: Missing. | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Propeptide | 1 – 320 | 320 | PRO_0000015639 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Chain | 321 – 993 | 673 | Type II inositol-1,4,5-trisphosphate 5-phosphatase | PRO_0000015640 | ||||||||||||||||||||||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 821 – 993 | 173 | Rho-GAP | |||||||||||||||||||||||||||||||||||||||||||||||||
| Region | 459 – 460 | 2 | Substrate | |||||||||||||||||||||||||||||||||||||||||||||||||
| Region | 582 – 583 | 2 | Substrate binding | |||||||||||||||||||||||||||||||||||||||||||||||||
| Region | 596 – 598 | 3 | Substrate binding | |||||||||||||||||||||||||||||||||||||||||||||||||
Sites | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Binding site | 383 | 1 | Substrate | |||||||||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Lipidation | 990 | 1 | S-farnesyl cysteine Potential | |||||||||||||||||||||||||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 1 – 244 | 244 | Missing in isoform 3. | VSP_012821 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 178 – 257 | 80 | Missing in isoform 2. | VSP_012820 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 810 – 828 | 19 | TLMPV…DSPME → LAYLAAYCFETQLVTKSLI in isoform 4. | VSP_013902 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 829 – 993 | 165 | Missing in isoform 4. | VSP_013903 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 46 | 1 | G → S. Corresponds to variant rs56993041 [ dbSNP | Ensembl ]. | VAR_061270 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 745 | 1 | M → T. Ref.1 Ref.3 Ref.5 Corresponds to variant rs11488569 [ dbSNP | Ensembl ]. | VAR_028002 | ||||||||||||||||||||||||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 990 | 1 | C → S: Loss of prenylation and membrane localization. | |||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 587 – 606 | 20 | GSDDW…WCDRI → RALTTGIPVRSAVLLPGVIG F AA sequence Ref.5 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 911 | 1 | G → P AA sequence Ref.5 | |||||||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 340 – 349 | 10 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 364 – 367 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 375 – 379 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 388 – 391 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 398 – 407 | 10 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 416 – 423 | 8 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 428 – 434 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 435 – 440 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 441 – 447 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 464 – 469 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 472 – 478 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 485 – 487 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 488 – 501 | 14 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 509 – 511 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 518 – 525 | 8 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 537 – 545 | 9 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 549 – 553 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 557 – 563 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 607 – 609 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 614 – 620 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 626 – 629 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 632 – 638 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 640 – 643 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Properties of type II inositol polyphosphate 5-phosphatase." Jefferson A.B., Majerus P.W. J. Biol. Chem. 270:9370-9377(1995) [PubMed: 7721860] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAT LOCATION, ISOPRENYLATION AT CYS-990, MUTAGENESIS OF CYS-990, VARIANT THR-745. |
| [2] | "The DNA sequence and biological annotation of human chromosome 1." Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K. Bentley D.R.Nature 441:315-321(2006) [PubMed: 16710414] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (ISOFORMS 1; 2 AND 3). |
| [3] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), VARIANT THR-745. Tissue: Lymph. |
| [4] | "The full-ORF clone resource of the German cDNA consortium." Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., Wiemann S., Schupp I. BMC Genomics 8:399-399(2007) [PubMed: 17974005] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-178. Tissue: Stomach. |
| [5] | "Cloning and expression of human 75-kDa inositol polyphosphate-5-phosphatase." Ross T.S., Jefferson A.B., Mitchell C.A., Majerus P.W. J. Biol. Chem. 266:20283-20289(1991) [PubMed: 1718960] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 284-954, PROTEIN SEQUENCE OF 321-339, VARIANT THR-745. Tissue: Placenta. |
| [6] | "Two closely related endocytic proteins that share a common OCRL-binding motif with APPL1." Swan L.E., Tomasini L., Pirruccello M., Lunardi J., De Camilli P. Proc. Natl. Acad. Sci. U.S.A. 107:3511-3516(2010) [PubMed: 20133602] [Abstract] Cited for: INTERACTION WITH FAM109A. |
| [7] | "The PH domain proteins IPIP27A and B link OCRL1 to receptor recycling in the endocytic pathway." Noakes C.J., Lee G., Lowe M. Mol. Biol. Cell 22:606-623(2011) [PubMed: 21233288] [Abstract] Cited for: INTERACTION WITH FAM109A AND FAM109B. |
| [8] | "Crystal structure of INPP5B in complex with phosphatidylinositol 4-phosphate (CASP target)." Structural genomics consortium (SGC) Submitted (JUL-2010) to the PDB data bank Cited for: X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 339-646 IN COMPLEX WITH PHOSPHATIDYLINOSITOL 4-PHOSPHATE. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | M74161 mRNA. Translation: AAA79207.1. Different initiation. AL603790, AL929472 Genomic DNA. Translation: CAH69926.1. AL603790, AL929472 Genomic DNA. Translation: CAH69928.1. AL603790, AL929472 Genomic DNA. Translation: CAH69929.1. AL929472, AL603790 Genomic DNA. Translation: CAH70076.1. AL929472, AL603790 Genomic DNA. Translation: CAH70079.1. AL929472, AL603790 Genomic DNA. Translation: CAH70080.1. BX296560 Genomic DNA. No translation available. BC042529 mRNA. Translation: AAH42529.2. BC058932 mRNA. Translation: AAH58932.1. AL833055 mRNA. Translation: CAH56301.1. | ||||||||||||||||||
| IPI | IPI00244111. IPI00478376. IPI00553072. IPI00604769. | ||||||||||||||||||
| RefSeq | NP_005531.2. NM_005540.2. | ||||||||||||||||||
| UniGene | Hs.449942. | ||||||||||||||||||
3D structure databases | |||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||
| ProteinModelPortal | P32019. | ||||||||||||||||||
| SMR | P32019. Positions 1-155, 339-643, 656-992. | ||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||
| STRING | P32019. | ||||||||||||||||||
PTM databases | |||||||||||||||||||
| PhosphoSite | P32019. | ||||||||||||||||||
Polymorphism databases | |||||||||||||||||||
| DMDM | 281185510. | ||||||||||||||||||
Proteomic databases | |||||||||||||||||||
| PRIDE | P32019. | ||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||
Genome annotation databases | |||||||||||||||||||
| Ensembl | ENST00000373023; ENSP00000362114; ENSG00000204084. ENST00000373026; ENSP00000362117; ENSG00000204084. | ||||||||||||||||||
| GeneID | 3633. | ||||||||||||||||||
| KEGG | hsa:3633. | ||||||||||||||||||
| UCSC | uc001ccf.1. human. uc001ccg.1. human. uc009vvk.1. human. | ||||||||||||||||||
Organism-specific databases | |||||||||||||||||||
| CTD | 3633. | ||||||||||||||||||
| GeneCards | GC01M038326. | ||||||||||||||||||
| H-InvDB | HIX0199823. | ||||||||||||||||||
| HGNC | HGNC:6077. INPP5B. | ||||||||||||||||||
| HPA | HPA028803. | ||||||||||||||||||
| MIM | 147264. gene. | ||||||||||||||||||
| neXtProt | NX_P32019. | ||||||||||||||||||
| PharmGKB | PA29885. | ||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||
| eggNOG | prNOG04448. | ||||||||||||||||||
| GeneTree | ENSGT00590000082823. | ||||||||||||||||||
| HOVERGEN | HBG000070. | ||||||||||||||||||
| InParanoid | P32019. | ||||||||||||||||||
| OMA | GVAIRFQ. | ||||||||||||||||||
| PhylomeDB | P32019. | ||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||
| BioCyc | MetaCyc:ENSG00000134678-MONOMER. | ||||||||||||||||||
| BRENDA | 3.1.3.36. 2681. | ||||||||||||||||||
| Reactome | REACT_111102. Signal Transduction. | ||||||||||||||||||
Gene expression databases | |||||||||||||||||||
| ArrayExpress | P32019. | ||||||||||||||||||
| Bgee | P32019. | ||||||||||||||||||
| CleanEx | HS_INPP5B. | ||||||||||||||||||
| Genevestigator | P32019. | ||||||||||||||||||
| GermOnline | ENSG00000204084. Homo sapiens. | ||||||||||||||||||
Family and domain databases | |||||||||||||||||||
| InterPro | IPR005135. Endo/exonuclease/phosphatase. IPR000300. IPPc. IPR008936. Rho_GTPase_activation_prot. IPR000198. RhoGAP_dom. [Graphical view] | ||||||||||||||||||
| Gene3D | G3DSA:1.10.555.10. RhoGAP. 1 hit. | ||||||||||||||||||
| KO | K01099. | ||||||||||||||||||
| Pfam | PF03372. Exo_endo_phos. 1 hit. PF00620. RhoGAP. 1 hit. [Graphical view] | ||||||||||||||||||
| SMART | SM00128. IPPc. 1 hit. SM00324. RhoGAP. 1 hit. [Graphical view] | ||||||||||||||||||
| SUPFAM | SSF56219. Exo_endo_phos. 1 hit. SSF48350. Rho_GAP. 1 hit. | ||||||||||||||||||
| PROSITE | PS50238. RHOGAP. 1 hit. [Graphical view] | ||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||
Other | |||||||||||||||||||
| NextBio | 14219. | ||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||
Entry information
| Entry name | I5P2_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P32019 Secondary accession number(s): C9J6U5 Q86YE1 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 1 Human chromosome 1: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with